Blogs

INSIGHTS & ARTICLES

DnXT Blog

Expert insights on regulatory operations, eCTD publishing, and digital transformation in life sciences.

12 Questions to Ask Before Adopting AI in Regulatory Operations
Article

12 Questions to Ask Before Adopting AI in Regulatory Operations

A practical buyer's guide: 12 questions pharma and biotech companies should ask when evaluating AI-powered regulatory technology platforms.

May 21, 2026 Read more →
Continuous Compliance Monitoring: How DnXT Watches Its Own Platform
Regulatory Compliance

Continuous Compliance Monitoring: How DnXT Watches Its Own Platform

An inside look at DnXT's Compliance Monitoring Dashboard — 6 compliance agents, 8 daily checks, and how continuous monitoring catches problems before auditors do.

May 21, 2026 Read more →
The Case for an AI-Native Regulatory Platform (Not Another Bolt-On)
Digital Transformation

The Case for an AI-Native Regulatory Platform (Not Another Bolt-On)

Why life sciences may need regulatory platforms designed for AI from the ground up — and the honest counter-arguments to that position.

May 21, 2026 Read more →
What AI-Powered eCTD Validation Actually Looks Like in Practice
Product Features

What AI-Powered eCTD Validation Actually Looks Like in Practice

A practical look at eCTD validation: 23 compliance rules, multi-region support, and how AI helps with preparation while deterministic rules handle the actual checking.

May 21, 2026 Read more →
Building a Compliance Workflow Engine That AI Agents Can Drive
Product Features

Building a Compliance Workflow Engine That AI Agents Can Drive

A look inside DnXT's V5 workflow engine — 50+ endpoints, state machine architecture, and the preCheck pattern that lets AI agents look before they leap.

May 21, 2026 Read more →
Why AI Agents Should Never Sign Documents — And How to Enforce That
Regulatory Compliance

Why AI Agents Should Never Sign Documents — And How to Enforce That

Electronic signatures in regulated environments require human attribution. Here's why AI agents must be architecturally blocked from signing, not just told not to.

May 21, 2026 Read more →
AI in Regulatory Publishing: An Honest Comparison of Industry Approaches
Article

AI in Regulatory Publishing: An Honest Comparison of Industry Approaches

A balanced analysis of how Veeva, Kivo, DnXT, and generic AI platforms approach AI in regulatory publishing — strengths and limitations of each.

May 21, 2026 Read more →
Tenant Isolation in AI-Powered Regulatory Platforms: Why Architecture Matters
Regulatory Compliance

Tenant Isolation in AI-Powered Regulatory Platforms: Why Architecture Matters

A technical breakdown of four-layer tenant isolation in DnXT's regulatory platform, and why it matters when AI agents interact with regulated data.

May 21, 2026 Read more →
How We Built a 21 CFR Part 11 Audit Trail for AI-Initiated Actions
Regulatory Compliance

How We Built a 21 CFR Part 11 Audit Trail for AI-Initiated Actions

A technical look at how DnXT's audit trail infrastructure handles AI-initiated actions while maintaining 21 CFR Part 11 and ALCOA+ data integrity standards.

May 21, 2026 Read more →
Open GxP: How MCP Is Connecting AI Agents to Regulatory Compliance Systems
Digital Transformation

Open GxP: How MCP Is Connecting AI Agents to Regulatory Compliance Systems

How the Model Context Protocol enables AI agents to interact with GxP compliance systems while maintaining regulatory guardrails and audit integrity.

May 21, 2026 Read more →
AI in Regulatory Affairs Is Not a Feature — It’s an Infrastructure Decision
AI & Innovation

AI in Regulatory Affairs Is Not a Feature — It’s an Infrastructure Decision

Test excerpt update at 2026-04-10T23:20:09.336Z

Apr 9, 2026 Read more →
The Hidden Cost of Disconnected Regulatory Systems — And What Integration Actually Looks Like
Consulting Insights

The Hidden Cost of Disconnected Regulatory Systems — And What Integration Actually Looks Like

The Hidden Cost of Disconnected Regulatory Systems — And What Integration Actually Looks Like Walk into almost any mid-to-large pharma company’s regulatory department, and you’ll see a familiar sight: a...

Apr 9, 2026 Read more →